Free tool
Healthcare stocks
We cover 1,104 companies in the Healthcare sector. The median market value in the group is $40.76M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is 0.00%. 40% of the 976 with a 200-day average trade above it. Price change over the past year runs from −76.7% to +63.0% across the middle 80 percent of the group, with a median of −16.5%. Among those 1,000, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,104 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $148.77 | +13.98% | +23.04% | +32.85% |
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.00% | −81.40% | −78.95% |
| GIS.DE | Gilead Sciences, Inc. | 124.88 EUR | +6.55% | +21.56% | +29.53% |
| PFE.DE | Pfizer Inc. | 23.91 EUR | +7.95% | +15.85% | +18.09% |
| PFIZ34.SA | Pfizer Inc. | 36.50 BRL | +15.29% | +10.40% | +11.31% |
| PFE | Pfizer Inc. | $28.57 | +15.81% | +17.27% | +19.52% |
| DHR | Danaher Corporation | $215.97 | +9.91% | −6.06% | +4.52% |
| DHER34.SA | Danaher Corporation | 39.68 BRL | +11.43% | −10.83% | −0.75% |
| DAP.DE | Danaher Corporation | 184.70 EUR | +5.33% | −5.55% | +5.45% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 469.95 EUR | +10.56% | +22.24% | +40.14% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.83 BRL | +19.14% | −85.56% | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $552.85 | +15.42% | +22.28% | +42.14% |
| BMY | Bristol-Myers Squibb Company | $67.92 | +8.57% | +28.36% | +49.31% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| BRM.DE | Bristol-Myers Squibb Company | 57.33 EUR | +2.36% | +27.03% | +46.24% |
| IUI1.DE | Intuitive Surgical, Inc. | 322.70 EUR | +0.77% | −32.18% | −20.90% |
| ISRG | Intuitive Surgical, Inc. | $371.84 | +4.21% | −33.83% | −20.62% |
| I1SR34.SA | Intuitive Surgical, Inc. | 95.70 BRL | +2.99% | −37.63% | −24.38% |
| SYK | Stryker Corporation | $330.59 | −1.83% | −4.80% | −14.79% |
| S1YK34.SA | Stryker Corporation | 84.97 BRL | +5.72% | −13.76% | −17.50% |
| SYK.DE | STRYKER CORP. R | 282.10 EUR | −7.33% | −4.56% | +34.76% |
| MDTC34.SA | Medtronic plc | 59.28 BRL | +12.98% | −77.33% | −76.08% |
| 2M6.DE | Medtronic plc | 79.84 EUR | +4.23% | −1.17% | +3.67% |
| MDT | Medtronic plc | $91.14 | +8.22% | −4.34% | +1.33% |
| SNY | Sanofi | $46.02 | +4.59% | +0.71% | −3.11% |
| SAN.PA | Sanofi | 78.28 EUR | −1.39% | +0.41% | −4.49% |
| SNW.DE | Sanofi | 78.32 EUR | −0.94% | +0.25% | −4.28% |
| MCK | McKesson Corporation | $905.09 | +6.47% | +10.01% | +33.71% |
| GS71.DE | GSK plc | 22.16 EUR | −6.46% | +6.95% | +31.93% |
| G1SK34.SA | GSK plc | 53.80 BRL | +4.47% | +1.87% | +28.14% |
| GSK | GSK plc | $52.07 | +0.17% | +6.73% | +34.79% |
| GSK.L | GSK plc | 1,890.50 GBP | −6.83% | +3.24% | +28.03% |
| M1CK34.SA | McKesson Corporation | 72.24 BRL | +4.56% | −93.69% | −92.48% |
| HCA | HCA Healthcare, Inc. | $428.76 | +10.05% | −8.71% | +6.96% |
| H1CA34.SA | HCA Healthcare, Inc. | 110.44 BRL | +11.12% | −13.17% | +3.95% |
| A58.DE | Elevance Health, Inc. | 344.10 EUR | +3.43% | +14.34% | −18.92% |
| E1LV34.SA | Elevance Health, Inc. | 410.80 BRL | +3.62% | +6.85% | +21.66% |
| ELV | Elevance Health, Inc. | $398.87 | +5.42% | +13.29% | +29.17% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 706.90 EUR | +23.09% | +7.29% | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | 162.35 EUR | −3.31% | −37.24% | −38.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $833.56 | +24.94% | +7.66% | +46.21% |
| EL.PA | EssilorLuxottica Société anonyme | 161.70 EUR | −4.12% | −37.66% | −37.89% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 71.40 BRL | +25.51% | +2.94% | +37.96% |
| CI | The Cigna Group | $279.32 | −4.02% | +0.62% | −5.62% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −83.52% | −84.24% | −85.51% |
| CGN.DE | The Cigna Group | 238.50 EUR | −8.69% | +0.92% | −8.36% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 7,050.00 JPY | +0.73% | −17.21% | +12.47% |
| B1SX34.SA | Boston Scientific Corporation | 64.19 BRL | +9.06% | −87.53% | −88.79% |
| BSX | Boston Scientific Corporation | $49.86 | +9.56% | −47.36% | −52.56% |
| BSX.DE | Boston Scientific Corporation | 42.22 EUR | +2.65% | −47.62% | −54.21% |
| MRK.DE | Merck KGaA | 138.40 EUR | −4.06% | +16.39% | +30.60% |
| ARGX | argenx SE | $1,019.49 | +14.70% | +21.37% | +50.52% |
| M1RN34.SA | Moderna, Inc. | 40.95 BRL | +195.88% | +382.90% | +494.34% |
| 0QF.DE | Moderna, Inc. | 118.40 EUR | +147.16% | +349.85% | +461.14% |
| MRNA | Moderna, Inc. | $158.83 | +185.51% | +414.68% | +526.55% |
| A1RG34.SA | argenx SE | 209.16 BRL | +18.17% | +11.37% | +44.49% |
| COR | Cencora, Inc. | $328.06 | +5.43% | −2.80% | +14.44% |
| CSL.AX | CSL Limited | 174.44 AUD | +45.95% | +2.75% | −17.14% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,885.00 JPY | +2.45% | +21.80% | +39.50% |
| TAK | Takeda Pharmaceutical Company Limited | $18.35 | +5.22% | +17.48% | +21.77% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +12.06% | +12.61% | +16.07% |
| BAYN.DE | Bayer Aktiengesellschaft | 48.48 EUR | +3.08% | +27.94% | +71.10% |
| CAH | Cardinal Health, Inc. | $237.92 | +3.74% | +15.93% | +64.25% |
| C1AH34.SA | Cardinal Health, Inc. | 1,222.80 BRL | +3.96% | +5.76% | +50.94% |
| BAY.WA | Bayer Aktiengesellschaft | 206.70 PLN | +0.68% | +31.69% | +71.25% |
| 207940.KS | Samsung Biologics Co.,Ltd. | 1,609,000.00 KRW | +3.87% | −4.40% | +2.60% |
| C1CO34.SA | Cencora, Inc. | 707.04 BRL | 0.00% | −22.88% | −12.17% |
| EW | Edwards Lifesciences Corporation | $90.87 | +9.43% | +6.49% | +12.38% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +2.94% |
| EWL.DE | Edwards Lifesciences Corporation | 77.46 EUR | +5.33% | +7.79% | +10.23% |
| SHL.DE | Siemens Healthineers AG | 40.39 EUR | +12.44% | −6.30% | −12.35% |
| B1DX34.SA | Becton, Dickinson and Company | 195.72 BRL | +39.80% | −113.58% | −113.87% |
| BDX | Becton, Dickinson and Company | $189.78 | +19.42% | +24.62% | +26.17% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.55% | +2.32% | +29.26% |
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| E1WL34.SA | Edwards Lifesciences Corporation | 105.71 BRL | 0.00% | −8.81% | −4.72% |
| MDLN | Medline Inc. | $35.64 | −10.23% | −12.26% | −13.07% |
| HUM | Humana Inc. | $389.71 | +2.25% | +48.10% | +32.71% |
| H1UM34.SA | Humana Inc. | 44.50 BRL | +0.29% | +39.03% | +24.30% |
| RVMD | Revolution Medicines, Inc. | $211.38 | +12.39% | +167.50% | +492.60% |
| HLN | Haleon plc | $10.18 | +2.41% | +3.15% | +6.56% |
| H6D0.DE | Haleon plc | 4.34 EUR | −3.10% | +2.77% | +4.86% |
| TEVA | Teva Pharmaceutical Industries Limited | $38.10 | +22.59% | +23.10% | +110.26% |
| HLN.L | Haleon plc | 369.80 GBP | −2.91% | −0.07% | +2.08% |
| I1DX34.SA | IDEXX Laboratories, Inc. | 578.89 BRL | +0.85% | −23.36% | −16.38% |
| IDXX | IDEXX Laboratories, Inc. | $550.01 | −1.11% | −17.91% | −14.24% |
| A | Agilent Technologies, Inc. | $154.77 | +12.24% | +12.65% | +30.69% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| IX1.DE | IDEXX Laboratories, Inc. | 468.10 EUR | −2.09% | −17.59% | +17.97% |
| IQV | IQVIA Holdings Inc. | $259.42 | +21.67% | +15.11% | +37.97% |
| QTS.DE | IQVIA Holdings Inc. | 222.40 EUR | +19.51% | +15.38% | −3.91% |
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| V2EE34.SA | Veeva Systems Inc. | 43.28 BRL | +37.40% | +4.74% | −16.69% |
| WAT | Waters Corporation | $414.44 | +11.65% | +8.50% | +38.63% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,350.00 JPY | +8.48% | +36.48% | +58.81% |
| VEEV | Veeva Systems Inc. | $246.78 | +26.91% | +12.43% | −13.47% |
| VEE.DE | Veeva System Inc. R | 212.20 EUR | +19.28% | +13.08% | +13.96% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | −78.40% | −81.18% | −77.11% |
| WATC34.SA | Waters Corporation | 476.58 BRL | 0.00% | −9.22% | +24.76% |
| ALC | Alcon Inc. | $73.37 | +9.05% | −4.99% | −8.71% |
| RPRX | Royalty Pharma plc | $62.07 | +5.69% | +61.27% | +75.10% |
| 2U3.DE | Alcon Inc. | 62.96 EUR | +3.86% | −4.24% | −10.05% |
| DC4.DE | DexCom, Inc. | 79.20 EUR | +19.28% | +40.28% | +21.55% |
| RMD | ResMed Inc. | $236.59 | +16.50% | −2.85% | −16.58% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| RMD.AX | ResMed Inc. | 32.95 AUD | +13.82% | −8.56% | −24.73% |
| ILU.DE | Illumina, Inc. | 186.94 EUR | +10.93% | +64.33% | +119.28% |
| ILMN | Illumina, Inc. | $224.99 | +18.75% | +67.47% | +125.76% |
| D1EX34.SA | DexCom, Inc. | 9.23 BRL | +28.73% | +23.23% | +11.74% |
| DXCM | DexCom, Inc. | $89.16 | +21.52% | +33.99% | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $73.91 | +20.93% | −10.68% | −0.78% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,923.00 JPY | +1.16% | −16.08% | −15.95% |
| IDP.DE | Biogen Inc. | 184.26 EUR | +3.59% | +22.59% | +57.35% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.81% |
| BIIB | Biogen Inc. | $220.77 | +10.31% | +24.15% | +61.90% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +10.54% | +16.95% | +47.86% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $240.08 | −13.76% | −40.01% | −45.88% |
| CNC | Centene Corporation | $65.00 | +1.44% | +55.58% | +123.52% |
| ZTS | Zoetis Inc. | $77.29 | +0.48% | −38.09% | −49.59% |
| 068270.KS | Celltrion, Inc. | 193,000.00 KRW | +8.79% | −4.69% | +13.47% |
| Z1TS34.SA | Zoetis Inc. | 24.84 BRL | +2.01% | −41.15% | −52.14% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 200.50 EUR | −20.91% | −41.22% | −11.75% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 61.14 BRL | −11.65% | −45.14% | −49.89% |
| ZOE.DE | Zoetis Inc. | 65.68 EUR | −4.92% | −38.06% | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | 46.04 EUR | +3.93% | −0.86% | +1.55% |
| 22UA.DE | BioNTech SE | 96.05 EUR | +19.17% | +16.49% | +8.53% |
| B1NT34.SA | BioNTech SE | 36.76 BRL | +25.42% | +11.90% | +3.26% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| MTD | Mettler-Toledo International Inc. | $1,402.25 | +4.94% | −0.65% | +8.72% |
| MTO.DE | Mettler-Toledo International Inc. | 1,222.00 EUR | +4.27% | +2.22% | +13.15% |
| 4503.T | Astellas Pharma Inc. | 2,430.50 JPY | +8.82% | +15.84% | +56.44% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| R1MD34.SA | ResMed Inc. | 243.85 BRL | 0.00% | −26.80% | −38.24% |
| INSM | Insmed Incorporated | $123.89 | +18.29% | −30.05% | −3.45% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| PHG | Koninklijke Philips N.V. | $27.52 | +9.99% | +5.62% | +3.60% |
| PHI1.DE | Koninklijke Philips N.V. | 23.61 EUR | +6.59% | +6.08% | +2.84% |
| INCY | Incyte Corporation | $129.72 | +9.13% | +27.90% | +53.04% |
| ROIV | Roivant Sciences Ltd. | $36.47 | +5.04% | +66.30% | +213.32% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $348.48 | +5.27% | +26.29% | +41.31% |
| 4543.T | Terumo Corporation | 2,610.00 JPY | +14.02% | +16.18% | −1.19% |
| SIG.AX | Sigma Healthcare Limited | 2.85 AUD | −1.90% | −2.52% | −5.33% |
| STE | STERIS plc | $236.44 | +8.26% | −5.20% | −4.35% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 191.20 EUR | +12.47% | −7.79% | +10.02% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 192.70 EUR | +18.51% | −7.80% | +10.46% |
| GH | Guardant Health, Inc. | $164.92 | +13.37% | +62.10% | +166.52% |
| THC | Tenet Healthcare Corporation | $278.59 | +14.48% | +39.68% | +54.57% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| GE9.DE | GENMAB AS N | 283.30 EUR | +10.97% | +5.71% | −14.41% |
| GMAB.CO | Genmab A/S | 2,112.00 DKK | +10.69% | +5.23% | +33.08% |
| SRT3.DE | Sartorius Aktiengesellschaft | 243.10 EUR | +9.31% | −1.56% | +26.10% |
| S1TE34.SA | STERIS plc | 52.14 BRL | 0.00% | −19.10% | −18.78% |
| VTRS | Viatris Inc. | $16.72 | −5.22% | +36.33% | +62.88% |
| VIA.DE | Viatris Inc. | 14.01 EUR | −10.10% | +35.52% | +62.09% |
| ZBH | Zimmer Biomet Holdings, Inc. | $100.24 | +8.87% | +11.66% | −5.86% |
| QS51.DE | Straumann Holding AG | 99.50 EUR | −4.33% | −1.65% | +0.41% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | 121.92 BRL | +6.75% | +6.21% | −5.04% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 452.00 SEK | −3.17% | +36.80% | +54.48% |
| MEDP | Medpace Holdings, Inc. | $614.06 | +4.19% | +7.54% | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $260.23 | +1.88% | +50.29% | +108.87% |
| ASND | Ascendis Pharma A/S | $252.99 | −0.17% | +18.61% | +32.89% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.20% | −12.68% | −20.81% |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +6.10% | −5.48% | +7.28% |
| IPN.PA | Ipsen S.A. | 162.60 EUR | +1.37% | +40.05% | +39.21% |
| BBIO | BridgeBio Pharma, Inc. | $80.40 | −4.42% | +2.77% | +70.01% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 37.54 AUD | +11.83% | +15.97% | +13.60% |
| SRT.DE | Sartorius Aktiengesellschaft | 193.00 EUR | +9.53% | −0.29% | +22.06% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | 39.72 BRL | −10.70% | −1.49% | +7.58% |
| 4507.T | Shionogi & Co., Ltd. | 2,942.00 JPY | +1.36% | +3.81% | +17.95% |
| SOLV | Solventum Corporation | $91.61 | +13.84% | +15.93% | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $153.37 | −13.06% | +9.08% | +14.46% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 36.07 BRL | +7.35% | −10.50% | +5.51% |
| C1OO34.SA | The Cooper Companies, Inc. | 39.92 BRL | +6.97% | −13.31% | −0.30% |
| ERF.PA | Eurofins Scientific SE | 73.26 EUR | +6.92% | +19.56% | +13.76% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +6.29% | +17.51% | +11.02% |
| 7733.T | Olympus Corporation | 2,164.00 JPY | +20.09% | +8.49% | +26.42% |
| COO | The Cooper Companies, Inc. | $73.04 | +3.91% | −9.95% | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $297.64 | +32.70% | +47.04% | +81.37% |
| PME.AX | Pro Medicus Limited | 188.01 AUD | +15.24% | −15.32% | −38.33% |
| EXEL | Exelixis, Inc. | $56.72 | +1.63% | +30.15% | +49.66% |
| RVTY | Revvity, Inc. | $124.84 | +15.52% | +27.37% | +35.78% |
| B1AX34.SA | Baxter International Inc. | 67.70 BRL | +23.99% | +27.70% | +2.30% |
| BAX | Baxter International Inc. | $26.29 | +12.64% | +34.89% | +7.91% |
| ICLR | ICON Public Limited Company | $168.91 | +0.08% | −10.47% | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $123.57 | +35.61% | +223.48% | +79.56% |
| ORNBV.HE | Orion Oyj | 79.10 EUR | −2.04% | +26.66% | +16.59% |
| ORNAV.HE | Orion Oyj | 79.00 EUR | −1.86% | +27.30% | +17.12% |
| S1NN34.SA | Smith & Nephew plc | 31.62 BRL | 0.00% | −9.99% | −20.44% |
| BMRN | BioMarin Pharmaceutical Inc. | $66.12 | +9.71% | +11.22% | +13.03% |
| PEN | Penumbra, Inc. | $324.37 | +1.53% | +4.83% | +22.79% |
| FME.DE | Fresenius Medical Care AG | 40.14 EUR | −7.23% | +3.92% | −3.50% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.73% | +10.68% | +2.09% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $88.88 | +3.92% | +31.11% | +329.16% |
| FMS | Fresenius Medical Care AG | $23.51 | −5.47% | +4.03% | −3.29% |
| R1VT34.SA | Revvity, Inc. | 20.60 BRL | +3.00% | +10.27% | +22.81% |
| HALO | Halozyme Therapeutics, Inc. | $109.32 | +34.17% | +55.48% | +51.39% |
| TEM | Tempus AI, Inc. | $68.73 | +60.17% | +10.21% | −9.45% |
| SNN | Smith & Nephew plc | $29.22 | −6.11% | −9.78% | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $25.09 | −1.26% | +11.41% | +41.03% |
| SN.L | Smith & Nephew plc | 1,082.00 GBP | −9.83% | −11.12% | −21.69% |
| EHC | Encompass Health Corporation | $120.14 | +5.50% | +13.17% | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $512.16 | −7.09% | −13.76% | +24.24% |
| A1LG34.SA | Align Technology, Inc. | 208.52 BRL | −8.16% | −2.37% | +7.83% |
| DVA | DaVita Inc. | $177.80 | −24.76% | +55.27% | +29.47% |
| ALGN | Align Technology, Inc. | $159.61 | −5.02% | +2.29% | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $57.23 | −20.49% | +49.04% | +137.67% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| TECH | Bio-Techne Corporation | $72.33 | +0.99% | +21.65% | +28.12% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| GMED | Globus Medical, Inc. | $82.96 | +6.02% | −4.97% | +35.16% |
| DVAI34.SA | DaVita Inc. | 913.56 BRL | −24.60% | +40.43% | +15.68% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| CYTK | Cytokinetics, Incorporated | $77.46 | −3.92% | +25.48% | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $205.48 | −13.80% | +14.99% | +76.67% |
| GKOS | Glaukos Corporation | $181.39 | +19.41% | +63.83% | +98.13% |
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.57 | +13.60% | −20.21% | +52.01% |
| KRYS | Krystal Biotech, Inc. | $356.19 | +1.24% | +44.26% | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $126.64 | +15.07% | +74.05% | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $390.34 | +23.37% | +27.87% | +31.26% |
| ENSG | The Ensign Group, Inc. | $179.02 | +0.53% | +2.97% | +5.44% |
| ABVX.PA | ABIVAX Société Anonyme | 98.10 EUR | −9.83% | −14.70% | +42.59% |
| MOH | Molina Healthcare, Inc. | $199.63 | +0.08% | +11.86% | +13.96% |
| BIM.PA | bioMérieux S.A. | 74.35 EUR | −0.80% | −32.10% | −37.52% |
| UHS | Universal Health Services, Inc. | $175.76 | +10.33% | −19.99% | −4.14% |
| ABVX | ABIVAX Société Anonyme | $117.93 | −7.87% | −11.84% | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $12.34 | +4.84% | −10.97% | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $368.02 | +16.54% | +28.50% | +684.02% |
| RGEN | Repligen Corporation | $181.69 | +38.63% | +10.55% | +49.84% |
| HSIC | Henry Schein, Inc. | $89.65 | +5.96% | +16.70% | +30.93% |
| U1HS34.SA | Universal Health Services, Inc. | 222.89 BRL | +8.20% | −29.31% | −10.02% |
| APGE | Apogee Therapeutics, Inc. | $134.85 | +0.42% | +77.95% | +265.05% |
| RHCPA.AX | Ramsay Health Care Limited | 107.57 AUD | −0.40% | +0.44% | +0.44% |
| PTGX | Protagonist Therapeutics, Inc. | $150.59 | +11.09% | +72.73% | +164.75% |
| KLRS | Kalaris Therapeutics, Inc. | $4.20 | +17.32% | −49.40% | +67.33% |
| GOSS | Gossamer Bio, Inc. | $0.20 | +2.76% | −92.90% | −91.33% |
| ILA.AX | Island Pharmaceuticals Limited | 0.47 AUD | +20.51% | +8.05% | +104.35% |
| 4BB.L | 4basebio PLC | 470.00 GBP | −10.48% | −23.58% | −46.89% |
| NANOFS.ST | Nanoform Finland Oyj | 10.56 SEK | +8.87% | −18.01% | +12.70% |
| ATRA | Atara Biotherapeutics, Inc. | $9.84 | +27.63% | −44.63% | −19.61% |
| PARK | Park Dental Partners, Inc. | $20.46 | +3.70% | +38.24% | +99.61% |
| CGTX | Cognition Therapeutics, Inc. | $1.03 | +8.54% | −29.93% | −67.61% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 67.00 SEK | +3.55% | +34.54% | +14.33% |
| 4563.T | AnGes, Inc. | 39.00 JPY | −17.02% | −39.06% | −56.67% |
| ABNX.PA | ABIONYX Pharma SA | 1.94 EUR | +1.25% | −50.45% | −16.20% |
| 88Q.DE | 4basebio PLC | 5.25 EUR | +5.00% | −21.64% | −46.70% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | 0.23 AUD | +36.36% | −33.82% | −22.41% |
| NANOFH.HE | Nanoform Finland Oyj | 0.98 EUR | +11.67% | −17.29% | +13.49% |
| 4575.T | CanBas Co., Ltd. | 821.00 JPY | +12.47% | +0.24% | −40.51% |
| BIOPOR.CO | BioPorto A/S | 1.20 DKK | −0.41% | +15.16% | −6.25% |
| ADOC.PA | Adocia SA | 4.06 EUR | +2.53% | −39.67% | −46.72% |
| FBIO | Fortress Biotech, Inc. | $2.83 | −13.46% | −29.78% | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $1.87 | −4.59% | −94.66% | −94.66% |
| 004080.KS | Shinhung Co., Ltd | 14,100.00 KRW | +0.43% | +0.71% | +2.17% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.86 AUD | +29.55% | +3.64% | +67.65% |
| ALDX | Aldeyra Therapeutics, Inc. | $1.55 | −2.21% | −66.81% | −73.14% |
| ACRV | Acrivon Therapeutics, Inc. | $2.18 | +39.74% | −11.38% | +63.91% |
| 4579.T | RaQualia Pharma Inc. | 571.00 JPY | +26.05% | −41.26% | +4.58% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | 1.69 BRL | +19.86% | −26.84% | −8.15% |
| ALC.AX | Alcidion Group Limited | 0.10 AUD | +10.23% | −3.00% | −7.62% |
| HYPR | Hyperfine, Inc. | $0.87 | −9.49% | −10.24% | −30.42% |
| INIFY.OL | INIFY Laboratories AB | 6.70 NOK | −18.29% | +39.58% | +34.00% |
| VISTN.OL | Vistin Pharma ASA | 19.30 NOK | −3.50% | −0.97% | −15.47% |
| SGMO | Sangamo Therapeutics, Inc. | $0.22 | +83.33% | −50.00% | −56.86% |
| DWTX | Dogwood Therapeutics, Inc. | $2.68 | +75.16% | −36.79% | −47.04% |
| 4350.T | Medical System Network Co., Ltd. | 494.00 JPY | +0.82% | −3.38% | +6.47% |
| NANEXA.ST | Nanexa AB (publ) | 4.74 SEK | +18.82% | +17.64% | +109.51% |
| 4978.T | ReproCELL Incorporated | 148.00 JPY | +19.35% | +1.37% | −17.32% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | 5,300.00 KRW | +5.79% | −7.02% | +10.80% |
| EAH.L | ECO Animal Health Group plc | 101.00 GBP | +3.59% | −4.72% | +37.41% |
| CVRX | CVRx, Inc. | $3.37 | −30.94% | −52.54% | −54.77% |
| 7V0.DE | Novogenia AG | 6.10 EUR | −0.81% | −20.26% | −29.07% |
| RLYB | Rallybio Corporation | $16.89 | +3.53% | +198.53% | +262.65% |
| 3417.T | Ohki Healthcare Holdings Co.,Ltd. | 1,045.00 JPY | −0.67% | −24.84% | −15.91% |
| ICCC | ImmuCell Corporation | $9.84 | −11.59% | +66.22% | +61.58% |
| ACH | Accendra Health, Inc. | $1.16 | −63.98% | −50.00% | −77.39% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,136.00 JPY | +11.70% | +6.92% | −23.95% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.24 SEK | −1.58% | +212.78% | +76.27% |
| OSE.PA | OSE Immunotherapeutics SA | 3.19 EUR | +0.69% | −39.85% | −47.82% |
| 6678.T | Techno Medica Co., Ltd. | 2,082.00 JPY | +2.76% | −2.17% | +10.19% |
| 194A.T | WOLVES HAND CO LTD | 1,867.00 JPY | +43.50% | +7.61% | +100.75% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | 0.45 CAD | +28.57% | −19.64% | +246.15% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | 1,277.00 KRW | +2.24% | −17.61% | −21.42% |
| 002390.KS | HANDOK Inc. | 9,370.00 KRW | +7.09% | −15.27% | −20.23% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.95 BRL | −8.39% | −36.56% | −52.27% |
| TENX | Tenax Therapeutics, Inc. | $2.32 | −85.67% | −79.00% | −60.81% |
| SERA | Sera Prognostics, Inc. | $2.18 | +6.34% | −27.33% | −17.42% |
| MAIA | MAIA Biotechnology, Inc. | $1.41 | +10.16% | −11.88% | −10.76% |
| CTOR | Citius Oncology, Inc. | $0.81 | +45.70% | −24.99% | −57.14% |
| ECOR | electroCore, Inc. | $9.47 | +56.53% | +108.13% | +79.70% |
| CING | Cingulate Inc. | $5.87 | +29.87% | +34.02% | +39.60% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −6.36% | +26.85% | −1.90% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | 272.00 JPY | +9.24% | −9.63% | −10.10% |
| EQL.ST | EQL Pharma AB | 26.80 SEK | +29.78% | −54.73% | −67.71% |
| ACET | Adicet Bio, Inc. | $9.00 | +11.66% | +2.04% | −20.89% |
| HIGH.DE | Cantourage Group SE | 5.88 EUR | +4.63% | +77.11% | +45.19% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.94 | −7.66% | −40.48% | −17.53% |
| 7792.T | Colan Totte.Co.,Ltd. | 1,460.00 JPY | +0.69% | −1.02% | +4.31% |
| OBI.L | Ondine Biomedical Inc. | 12.25 GBP | −10.91% | +40.00% | −25.76% |
| AB.PA | AB Science S.A. | 0.67 EUR | +18.10% | −53.97% | −44.83% |
| RPID | Rapid Micro Biosystems, Inc. | $1.66 | −17.41% | −47.13% | −37.12% |
| GANX | Gain Therapeutics, Inc. | $1.91 | +2.42% | −40.09% | +3.53% |
| 002620.KS | Jeil Pharma Holdings Inc | 7,480.00 KRW | +7.94% | −8.22% | −14.27% |
| POLB.L | Poolbeg Pharma PLC | 8.50 GBP | +38.21% | +117.95% | +161.54% |
| HLS.TO | HLS Therapeutics Inc. | 3.84 CAD | −8.35% | −20.82% | −26.86% |
| 4888.T | Stella Pharma Corporation | 364.00 JPY | +17.42% | +71.70% | −9.23% |
| OKYO | OKYO Pharma Limited | $1.56 | −4.88% | −30.04% | −35.80% |
| TELO | Telomir Pharmaceuticals, Inc. | $1.18 | −4.07% | −11.94% | −19.18% |
| ATH.AX | Alterity Therapeutics Limited | 0.52 AUD | −1.89% | +15.56% | −20.00% |
| ATHE | Alterity Therapeutics Limited | $4.47 | −4.28% | +41.46% | −12.35% |
| RCE.AX | Recce Pharmaceuticals Ltd | 0.38 AUD | +2.74% | −43.82% | −12.79% |
| OM | Outset Medical, Inc. | $4.31 | −0.35% | +16.35% | −68.62% |
| DH | Definitive Healthcare Corp. | $0.75 | +11.90% | −68.24% | −81.10% |
| CRDF | Cardiff Oncology, Inc. | $1.02 | +21.43% | −61.65% | −53.85% |
| OMDA.OL | Omda AS | 35.50 NOK | −3.79% | −25.65% | −27.31% |
| ELTX | Elicio Therapeutics, Inc. | $3.01 | +0.33% | −62.61% | −72.71% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +9.05% | −34.60% | −76.93% |
| NXTMH.HE | Nexstim Plc | 9.16 EUR | −4.68% | −34.57% | −30.34% |
| MDG.WA | Medicalgorithmics S.A. | 28.95 PLN | +15.57% | −15.60% | −21.33% |
| ANVS | Annovis Bio, Inc. | $1.82 | +8.98% | −50.14% | −18.75% |
| MNOV | MediciNova, Inc. | $1.57 | +18.94% | +18.05% | +18.94% |
| 7775.T | Daiken Medical Co., Ltd. | 426.00 JPY | −0.47% | −2.38% | −3.06% |
| APLM | Apollomics, Inc. | $26.50 | +47.22% | +37.31% | +318.64% |
| OSTX | OS Therapies Incorporated | $1.65 | +7.84% | +23.13% | −24.66% |
| NRXS | NeurAxis, Inc. | $6.04 | −10.39% | +35.43% | +137.80% |
| ZTEK | Zentek Ltd. | $0.60 | +5.53% | −10.22% | −7.46% |
| LONA | LeonaBio, Inc. | $8.01 | +8.83% | +15.09% | +95.37% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | 2,759.00 JPY | −7.42% | −14.59% | −0.70% |
| 4875.T | MediciNova, Inc. | 242.00 JPY | +12.04% | +14.69% | +15.24% |
| PLRX | Pliant Therapeutics, Inc. | $1.14 | +5.56% | −8.80% | −23.49% |
| IBIO | iBio, Inc. | $1.47 | +1.38% | −27.23% | +72.94% |
| KOO.L | Kooth plc | 147.50 GBP | −6.05% | +28.26% | −6.94% |
| DRIO | DarioHealth Corp. | $7.39 | −1.07% | −29.75% | −32.82% |
| FBIOP | Fortress Biotech, Inc. | $18.30 | −2.66% | +80.12% | +141.55% |
| STX.L | Shield Therapeutics plc | 4.70 GBP | −18.97% | −52.28% | −41.98% |
| SPRO | Spero Therapeutics, Inc. | $1.23 | +4.24% | −47.66% | −33.51% |
| SAR.L | Sareum Holdings plc | 29.00 GBP | +31.82% | +70.59% | +38.10% |
| MDXH | MDxHealth SA | $0.79 | +88.71% | −77.00% | −83.84% |
| XBIT | XBiotech Inc. | $2.30 | +1.77% | −3.36% | −28.13% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.09 EUR | +3.81% | +80.18% | +89.35% |
| 7702.T | JMS Co.,Ltd. | 460.00 JPY | +2.00% | +5.87% | +6.67% |
| 2689.T | OLBA HEALTHCARE HOLDINGS, Inc. | 1,877.00 JPY | −1.47% | −9.02% | −7.22% |
| EXOZ | eXoZymes, Inc. | $7.53 | +65.49% | −31.48% | −19.12% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +10.59% | +6.10% | −8.10% |
| INCR | InterCure Ltd. | $5.88 | +551.16% | +470.87% | +254.22% |
| ZLNA.OL | Zelluna ASA | 21.10 NOK | −6.22% | +50.71% | +45.70% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | 68.00 JPY | +9.68% | +61.90% | +30.77% |
| CSBR | Champions Oncology, Inc. | $4.98 | −17.82% | −25.23% | −29.46% |
| 9341.T | GENOVA, Inc. | 637.00 JPY | +0.95% | +14.02% | +2.20% |
| RNTX | Rein Therapeutics Inc. | $0.80 | +2.30% | −36.00% | −32.20% |
| NNOX | Nano-X Imaging Ltd. | $0.86 | −2.60% | −69.51% | −77.81% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.11 AUD | +5.00% | −67.19% | −19.23% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 13.20 SEK | +8.55% | −31.25% | −15.92% |
| INMB | INmune Bio Inc. | $2.43 | +40.46% | +57.79% | +8.48% |
| BOLD | Boundless Bio, Inc. | $2.94 | +18.55% | +140.98% | +160.18% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 309.00 JPY | +16.17% | +8.73% | +2.98% |
| 2934.T | J Frontier Co.,Ltd. | 1,994.00 JPY | +10.23% | +51.40% | +5.78% |
| SER | Serina Therapeutics, Inc. | $2.70 | +28.57% | +29.93% | −52.13% |
| MAAT.PA | MaaT Pharma SA | 3.05 EUR | +8.75% | −45.43% | −39.58% |
| HYFT | MindWalk Holdings Corp. | $1.42 | −1.39% | −29.70% | −48.55% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.36% | −66.26% | −65.91% |
| HEALTH.HE | Nightingale Health Oyj | 0.91 EUR | +5.83% | −56.35% | −58.91% |
| LTP.AX | LTR PHARMA FPO [LTP] | 0.49 AUD | 0.00% | −30.99% | −2.00% |
| GENT.OL | Gentian Diagnostics ASA | 38.50 NOK | −3.75% | −31.78% | −30.56% |
| AJ91.DE | DocCheck AG | 10.80 EUR | −6.09% | −14.29% | −9.24% |
| LYTIX.OL | Lytix Biopharma ASA | 7.70 NOK | −13.87% | −22.85% | −14.82% |
| ALGAE.PA | FERMENTALG | 0.46 EUR | −2.32% | +7.55% | −10.79% |
| R0L.F | J Frontier Co.,Ltd. | 10.40 EUR | +11.83% | −43.48% | −43.48% |
| RNXT | RenovoRx, Inc. | $1.42 | +47.15% | +70.06% | +58.13% |
| TLPH | Talphera, Inc. | $1.19 | −5.56% | +2.59% | +108.77% |
| IMA | ImageneBio, Inc. | $5.55 | −0.89% | −17.90% | −60.78% |
| SEZI.ST | Senzime AB (publ) | 3.80 SEK | +3.97% | −29.89% | −41.72% |
| AHC.AX | Austco Healthcare Limited | 0.23 AUD | +9.52% | −43.21% | −36.11% |
| 3079.T | DVx Inc. | 936.00 JPY | −1.37% | −17.85% | −7.86% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | 1,060.00 JPY | +12.77% | −46.07% | +124.11% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | 6.28 BRL | +0.96% | −3.38% | +31.66% |
| HRTX | Heron Therapeutics, Inc. | $0.32 | −29.76% | −74.36% | −76.59% |
| HVO.L | hVIVO plc | 6.54 GBP | −7.89% | +2.19% | −34.60% |
| 4263.T | SUSMED,Inc. | 574.00 JPY | −18.12% | −34.32% | −29.83% |
| INKT | MiNK Therapeutics, Inc. | $11.38 | +7.46% | +2.34% | −21.89% |
| 9265.T | Yamashita Health Care Holdings,Inc. | 3,750.00 JPY | +6.53% | +16.42% | +24.36% |
| XLO | Xilio Therapeutics, Inc. | $9.08 | −0.11% | −3.49% | −7.35% |
| NTRB | Nutriband Inc. | $4.83 | +62.08% | +9.03% | −24.59% |
| MYO | Myomo, Inc. | $1.48 | +39.62% | +49.49% | +35.78% |
| DXR | Daxor Corporation | $10.00 | −2.06% | −30.36% | −7.83% |
| V3V.DE | FamiCord AG | 2.85 EUR | −3.06% | −52.89% | −60.69% |
| 3446.T | JTEC Corporation | 1,566.00 JPY | +5.95% | +28.36% | +29.85% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | 1,292.00 JPY | +3.69% | +14.37% | −2.93% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +48.84% | +101.20% | +73.96% |
| 4524.T | Morishita Jintan Co., Ltd. | 2,245.00 JPY | +2.14% | +5.02% | +4.07% |
| FLUO.ST | FluoGuide A/S | 31.10 SEK | −1.27% | −15.72% | −21.07% |
| COCH | Envoy Medical, Inc. | $0.75 | +10.83% | +7.33% | −33.30% |
| SRTS | Sensus Healthcare, Inc. | $3.36 | +11.26% | −18.05% | +7.35% |
| BVC.L | BATM Advanced Communications Ltd. | 11.90 GBP | −7.39% | −25.86% | −24.80% |
| IMM.AX | Immutep Limited | 0.05 AUD | +14.89% | −87.44% | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +13.08% | −13.53% | −13.53% |
| 7776.T | CellSeed Inc. | 234.00 JPY | +13.59% | −16.13% | −47.42% |
| 4896.T | K Pharma,Inc. | 773.00 JPY | +4.46% | +15.37% | +15.89% |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% |
| ATYR | aTyr Pharma, Inc. | $0.57 | +16.33% | −24.90% | −88.95% |
| 4584.T | Kidswell Bio Corporation | 180.00 JPY | +28.57% | −15.09% | −24.37% |
| 4572.T | Carna Biosciences, Inc. | 416.00 JPY | +40.54% | +3.48% | +83.26% |
| GNTA | Genenta Science S.p.A. | $1.15 | −27.67% | −18.44% | −67.05% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −5.00% | −20.83% | −26.92% |
| AVE.AX | Avecho Biotechnology Limited | 0.02 AUD | 0.00% | +121.05% | +200.00% |
| 7963.T | Koken Ltd. | 1,818.00 JPY | +1.85% | −1.46% | +5.49% |
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| TELY.TO | TelyRx Holdings Inc. | 2.85 CAD | −1.04% | −18.57% | −18.57% |
| ALKLH.PA | KLEA HOLDING | 0.16 EUR | −1.90% | −30.34% | −29.55% |
| ALSMA.PA | S.M.A.I.O S.A. | 7.66 EUR | −4.25% | +24.55% | +13.48% |
| 4571.T | Nano Holdings, Inc. | 105.00 JPY | +10.53% | −26.06% | −30.00% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.50 SEK | −8.52% | −23.68% | −47.65% |
| ALTHE.PA | Theraclion SA | 0.64 EUR | +7.38% | +4.92% | −20.00% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +15.16% | +16.53% | +17.03% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.24 SEK | −37.02% | −66.26% | −76.41% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 580.00 GBP | −17.08% | +2.11% | +81.25% |
| BTMD | biote Corp. | $1.58 | −32.19% | −36.03% | −51.08% |
| SOM.AX | SomnoMed Limited | 0.34 AUD | −27.66% | −55.84% | −56.13% |
| 000230.KS | Ildong Holdings Co., Ltd. | 6,390.00 KRW | +7.04% | −51.50% | −27.92% |
| MOB.ST | Moberg Pharma AB (publ) | 10.12 SEK | +3.37% | −1.17% | +24.78% |
| 063160.KS | CKD Bio Corp. | 13,920.00 KRW | +6.91% | −31.60% | −39.08% |
| HYPD | Hyperion DeFi, Inc. | $3.41 | +33.20% | −4.75% | −44.10% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −3.13% | −33.33% | −26.19% |
| MODU.HE | Modulight Oyj | 1.07 EUR | +0.95% | −7.87% | −23.38% |
| HRTIS.HE | Herantis Pharma Oyj | 1.64 EUR | +3.02% | −28.47% | −4.21% |
| CLBIO.ST | Corline Biomedical AB | 18.35 SEK | +4.56% | +6.07% | +46.22% |
| TCRX | TScan Therapeutics, Inc. | $0.79 | +3.35% | −22.19% | −58.23% |
| SCYX | SCYNEXIS, Inc. | $5.19 | +45.38% | +712.21% | +514.20% |
| TIL | Instil Bio, Inc. | $7.81 | +9.23% | −30.70% | −69.62% |
| MDAI | Spectral AI, Inc. | $1.63 | −0.61% | +12.41% | −19.70% |
| 4597.T | Solasia Pharma K.K. | 29.00 JPY | 0.00% | +3.57% | −23.68% |
| 004720.KS | PharmGen Science, Inc. | 3,240.00 KRW | −1.07% | −26.36% | −27.52% |
| 9218.T | Mental Health Technologies Co.,Ltd. | 775.00 JPY | +4.45% | −4.67% | −5.89% |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.08 EUR | −5.11% | −56.26% | −66.16% |
| M3V.DE | MeVis Medical Solutions AG | 23.80 EUR | +4.39% | +0.39% | −0.42% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −15.00% | −18.07% | +58.14% |
| ORX.ST | Orexo AB (publ) | 13.40 SEK | −11.26% | −58.71% | −36.19% |
| CANTA.ST | Cantargia AB (publ) | 1.90 SEK | +1.71% | −53.86% | −28.93% |
| SVS.MI | Svas Biosana S.p.A. | 8.26 EUR | −4.18% | +3.25% | +0.73% |
| PHX.AX | PharmX Technologies Limited | 0.11 AUD | +5.00% | −30.00% | −4.55% |
| IBO | Impact BioMedical Inc. | $0.46 | +6.53% | −11.33% | −20.79% |
| 8769.T | Advantage Risk Management Co., Ltd. | 502.00 JPY | 0.00% | −15.52% | −11.34% |
| 002720.KS | Kukje Pharma Co., Ltd. | 3,310.00 KRW | +3.92% | −23.35% | −29.89% |
| ENZY.ST | Enzymatica AB (publ) | 1.85 SEK | +0.27% | −3.65% | −21.61% |
| 7096.T | StemCell Institute Inc. | 772.00 JPY | +6.63% | −2.03% | −21.54% |
| POCI | Precision Optics Corporation, Inc. | $4.41 | +3.52% | +3.76% | −9.07% |
| NSRX | Nasus Pharma Ltd. | $4.10 | +32.69% | −45.70% | −48.69% |
| M7T.AX | Mach7 Technologies Limited | 0.29 AUD | −5.00% | −57.78% | −9.52% |
| SVE.WA | Synthaverse S.A. | 3.04 PLN | +10.55% | −20.73% | −37.70% |
| IMMU.ST | Mendus AB (publ) | 6.98 SEK | +1.31% | +20.97% | −8.16% |
| 3628.T | Data Horizon Co.,Ltd. | 596.00 JPY | −2.61% | +20.40% | +9.96% |
| QTI | QT Imaging Holdings, Inc. | $3.24 | +19.56% | −45.55% | −90.73% |
| 3671.T | Softmax Co., Ltd | 311.00 JPY | −5.18% | −9.06% | −7.57% |
| CYC.AX | Cyclopharm Limited | 0.53 AUD | +0.96% | −46.70% | −47.50% |
| OSSD.ST | OssDsign AB (publ) | 4.07 SEK | −4.35% | −63.98% | −71.22% |
| MCRB | Seres Therapeutics, Inc. | $5.00 | +3.09% | −67.00% | −74.00% |
| ALGS | Aligos Therapeutics, Inc. | $7.47 | +83.09% | −18.18% | −26.84% |
| GRCE | Grace Therapeutics, Inc. | $2.20 | −4.35% | −39.89% | −32.31% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +12.77% | +8.16% | −33.75% |
| BIOBV.HE | Biohit Oyj | 2.56 EUR | −6.57% | −28.89% | −8.24% |
| FLNA | Filana Therapeutics, Inc. | $0.95 | +5.42% | −54.60% | −56.07% |
| NEPH | Nephros, Inc. | $4.22 | +23.03% | −11.16% | +0.72% |
| AIAI.TO | NetraMark Holdings Inc. | 0.70 CAD | −1.41% | −36.36% | −59.54% |
| MGX | Metagenomi Therapeutics, Inc. | $1.21 | 0.00% | −27.54% | −35.64% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +11.43% | +21.87% | +5.41% |
| 4890.T | Tsubota Laboratory Incorporated | 280.00 JPY | +18.14% | −14.37% | −23.50% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.36 EUR | −1.67% | −38.54% | −47.32% |
| MREO | Mereo BioPharma Group plc | $0.28 | −6.75% | −44.78% | −83.82% |
| XTNT | Xtant Medical Holdings, Inc. | $0.32 | −27.30% | −57.35% | −50.02% |
| IXHL | Incannex Healthcare Inc. | $3.75 | +25.63% | −67.95% | −83.13% |
| 3386.T | Cosmo Bio Company,Limited | 1,248.00 JPY | −2.04% | −4.29% | +6.78% |
| TVGN | Tevogen Inc. | $6.97 | +25.13% | −61.70% | −84.85% |
| 2370.T | MEDINET Co., Ltd. | 25.00 JPY | +4.17% | −13.79% | −34.21% |
| 6059.T | UCHIYAMA HOLDINGS Co.,Ltd. | 360.00 JPY | +4.35% | −2.43% | +12.60% |
| 9340.T | ASO International, Inc. | 712.00 JPY | −0.42% | −2.06% | −1.19% |
| CTE.AX | Cryosite Limited | 1.25 AUD | +4.17% | +25.00% | +56.25% |
| 3750.T | ADR Biomedical Holdings Inc. | 773.00 JPY | −0.64% | −9.48% | −15.61% |
| ALCOX.PA | Nicox S.A. | 0.38 EUR | +1.46% | +22.40% | +4.08% |
| 4880.T | CellSource Co., Ltd. | 347.00 JPY | +10.51% | −13.25% | −41.78% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +14.60% | +22.38% | +8.44% |
| NCYT.L | Novacyt S.A. | 44.00 GBP | +20.55% | +22.39% | +9.18% |
| MLSS | Milestone Scientific Inc. | $0.49 | +21.25% | +67.24% | −17.80% |
| HOWL | Werewolf Therapeutics, Inc. | $0.89 | +96.47% | +37.98% | −35.04% |
| EDSA | Edesa Biotech, Inc. | $4.45 | −16.82% | +196.67% | +83.88% |
| 4583.T | Chiome Bioscience Inc. | 85.00 JPY | +25.00% | −20.56% | −36.57% |
| 000220.KS | Yuyu Pharma, Inc. | 3,760.00 KRW | +6.21% | −18.08% | −11.54% |
| OPTOMED.HE | Optomed Oyj | 1.68 EUR | −0.24% | −55.57% | −54.67% |
| VVEO3.SA | CM Hospitalar S/A | 0.69 BRL | +6.15% | −48.89% | −24.18% |
| ELUT | Elutia Inc. | $1.01 | +5.21% | +57.08% | −57.74% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.92 | −72.92% | −73.30% | −69.57% |
| MVP.AX | Medical Developments International Limited | 0.54 AUD | +18.89% | −2.73% | −13.01% |
| PMED.MI | Piu' Medical | 5.60 EUR | +4.67% | −6.67% | −3.55% |
| LGP.AX | Little Green Pharma Ltd | 0.07 AUD | −6.67% | −46.15% | −44.00% |
| MOC.WA | Molecure S.A. | 6.14 PLN | +2.33% | −6.40% | −21.18% |
| SHG.AX | Singular Health Group Ltd | 0.18 AUD | −13.58% | −33.96% | −47.76% |
| ONCIN.OL | Oncoinvent ASA | 84.20 NOK | −3.00% | +79.15% | +11.35% |
| PAVM | PAVmed Inc. | $5.28 | +1.44% | −28.04% | −64.04% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.